New senior VP and VP for Bayer Consumer Health

, , ,

 

Brenda L. Raphael was appointed senior VP and general manager of Bayer’s Therapeutics Business Unit of Consumer Health Commercial Operations North America. Jennifer Brendel is now VP of communications for Bayer’s Consumer Health Division in the United States.

Brenda Raphael, Senior Vice President and General Manager of Therapeutics Business Unit for Bayer Consumer Health (PRNewsfoto/Bayer)

“Brenda has more than 20 years of experience in leading successful billion-dollar, consumer-focused brands,” says Natalie Bartner, president of North America Consumer Health, Consumer Health Division, Bayer. “Her strengths in understanding customers, marketing and innovation will lead the Therapeutics Business Unit to continue developing self-care solutions that help people live healthier lives.”

Raphael reports to Bartner and is a member of the Consumer Health North America Leadership Team. Raphael is based in Whippany, N.J. She joins Bayer from Pfizer Inc., where she most recently held the position of general manager for U.S. Brands in Pharma at the company’s New York City offices. She also previously held various senior positions at the Coca-Cola Company and Procter & Gamble.

With experience that spans pharmaceuticals and consumer products, executives say Raphael delivered significant financial gains to the businesses and insight-driven multi-channel marketing to consumers.

Jennifer Brendel, Vice President, Head of U.S. Bayer’s Consumer Health Communications (PRNewsfoto/Bayer)

Brendel, who spent the last 15 months leading Bayer’s Pharmaceutical Product Communications, is responsible for developing and executing external and internal communications strategies for some of the most well-known consumer health brands in the world, such as Aleve, Coppertone, and Aspirin.

Brendel reports directly to Raymond F. Kerins Jr., senior VP and head of Communications, Government Relations, and Policy for Bayer, and is the newest member of the U.S. Communications, Government Relations, and Policy Leadership Team.

“I am excited to have Jen take on this new leadership role as we continue to raise Bayer’s profile in the United States,” Kerins says. “Jen is a tremendous communications professional. Her years of experience managing major consumer brands plus her knowledge of our company’s strategy and values makes her perfectly suited to lead communications for the largest consumer health company in the United States, Bayer’s largest and fastest growing market.”

Before coming to Bayer, Brendel spent almost a decade at Pfizer in marketing and communications roles in the United States and Europe, most recently serving as the global marketing lead for Celebrex. Before that, she spent three years leading communications for Pfizer’s Rx-to-OTC switch portfolio. In this role Brendel led activities to raise awareness about the importance of self-care and increase receptivity to first-in-class over-the-counter medicines. Prior to joining Pfizer, Brendel spent time at several leading communications agencies in New York and Los Angeles and as a pharmaceutical sales representative.

“I am honored to begin this new opportunity here at Bayer at such a critical time of growth for the company,” Brendel says. “Bayer’s Consumer Health brands are some of the most cherished and trusted in the world. I look forward to helping these brands tell their stories, connect with consumers and continue to improve millions of lives here in the United States.”

Brendel holds a BA in Journalism from the University of Central Florida and is a resident of Hoboken, N.J.